ACADIA Pharmaceuticals Inc.

In News

ACADIA (NASDAQ: ACAD) director Jonathan Poole submits initial Form 3 insider report - Stock Titan

Stock Titan - Mar 20, 2026

Oppenheimer maintains a balanced outlook on ACADIA Pharmaceuticals Inc. (ACAD) for 2026 - MSN

MSN - Mar 18, 2026

Algert Global LLC Has $8.54 Million Stake in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat

MarketBeat - Mar 17, 2026

ACADIA Pharmaceuticals Maps Key CNS Readouts: Remlifanserin ADP Data Due Aug–Oct, ACP-211 Next Year - Yahoo Finance

Yahoo Finance - Mar 17, 2026

Acadia Pharmaceuticals Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Nasdaq - Mar 16, 2026

Acadia (NASDAQ: ACAD) director receives new option and RSU awards - Stock Titan

Stock Titan - Mar 20, 2026

Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum - Business Wire

Business Wire - Mar 12, 2026

ACADIA Pharmaceuticals (ACAD) Is Down 5.3% After EMA Rejects Trofinetide In Rett Review - What's Changed - Sahm

Sahm - Mar 16, 2026

Acadia, undaunted by recent EU rejection, seeks CHMP re-examination of Rett syndrome med Daybue - Fierce Pharma

Fierce Pharma - Mar 03, 2026

Acadia Pharmaceuticals: Undervalued Despite Robust Revenues From Approved Drugs, With Pipeline Kicker - Seeking Alpha

Seeking Alpha - Feb 28, 2026

Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech - BioSpace

BioSpace - Jan 13, 2026

Wolfe Research notes conviction-driven opportunities in ACADIA Pharmaceuticals Inc.’s (ACAD) therapeutic domains - MSN

MSN - Mar 18, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment